Letters to the Editor
Efficacy and safety of ixekizumab in psoriatic arthritis: a retrospective, single-centre, observational study in a real-life clinical setting
V. Manfreda1, M.S. Chimenti2, C. Canofari3, M. Esposito4, R. Perricone5, L. Bianchi6, A. Giunta7
- Department of Dermatology, University of Rome Tor Vergata, Rome, Italy. valeria.manfreda@gmail.com
- Department of Rheumatology, Allergology and Clinical Immunology, University of Rome Tor Vergata, Rome, Italy.
- Department of Rheumatology, Allergology and Clinical Immunology, University of Rome Tor Vergata, Rome, Italy.
- Department of Dermatology, University of Rome Tor Vergata, and Department of Dermatology, Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, Italy.
- Department of Rheumatology, Allergology and Clinical Immunology, University of Rome Tor Vergata, Rome, Italy.
- Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.
- Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.
CER12793
2020 Vol.38, N°3
PI 0581, PF 0582
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 32105590 [PubMed]
Received: 21/09/2019
Accepted : 25/11/2019
In Press: 04/02/2020
Published: 27/05/2020
